OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment
Lorenzo Gaetani, Federico Paolini Paoletti, G. Bellomo, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 12, pp. 1023-1037
Closed Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Solving neurodegeneration: common mechanisms and strategies for new treatments
Lauren K. Wareham, Shane A. Liddelow, Sally Temple, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 190

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
Özge Karayel, Sebastian Virreira Winter, Shalini Padmanabhan, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 6, pp. 100661-100661
Open Access | Times Cited: 109

Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
Nour F. Al-Ghraiybah, Junwei Wang, Amer E. Alkhalifa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10572-10572
Open Access | Times Cited: 90

α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies
G. Bellomo, Chiara Maria Giulia De Luca, Federico Paolini Paoletti, et al.
Neurology (2022) Vol. 99, Iss. 5, pp. 195-205
Closed Access | Times Cited: 89

Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status
Dorota Koníčková, Kateřina Menšíková, Lucie Tučková, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1760-1760
Open Access | Times Cited: 58

Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
Lorenzo Barba, Federico Paolini Paoletti, G. Bellomo, et al.
Movement Disorders (2022) Vol. 37, Iss. 4, pp. 669-683
Open Access | Times Cited: 57

Flexible electrochemical sensors integrated with nanomaterials for in situ determination of small molecules in biological samples: A review
Lin Tao, Yun Xu, Anshun Zhao, et al.
Analytica Chimica Acta (2022) Vol. 1207, pp. 339461-339461
Closed Access | Times Cited: 41

Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?
Simone Lista, Bruno P. Imbimbo, Margherita Grasso, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 14

A critical appraisal of blood-based biomarkers for Alzheimer’s disease
Simone Lista, Mark Mapstone, Filippo Caraci, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102290-102290
Closed Access | Times Cited: 12

Prospective biomarkers of Alzheimer’s disease: A systematic review and meta-analysis
Ruixian Li, Ya‐Hui Ma, Lan Tan, et al.
Ageing Research Reviews (2022) Vol. 81, pp. 101699-101699
Closed Access | Times Cited: 37

Electrochemical Biosensor for Point-of-Care Testing of Low-Abundance Biomarkers of Neurological Diseases
Ziyue Huang, Lei Zhang, Yanzhi Dou, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 25, pp. 10332-10340
Closed Access | Times Cited: 7

MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review
Hafiz Muhammad Husnain Azam, Rosa Rößling, Christiane Geithe, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 6

Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?
Gabriele Bonaventura, Antonio Munafò, Carlo Maria Bellanca, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1992-1992
Open Access | Times Cited: 33

Development of a Highly Sensitive Neurofilament Light Chain Assay on an Automated Immunoassay Platform
Stephen Lee, Tatiana Plavina, Carol M. Singh, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 26

Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?
Giuseppina Tesco, Selene Lomoio
Seminars in Immunology (2022) Vol. 59, pp. 101628-101628
Open Access | Times Cited: 25

Boosting mitochondrial health to counteract neurodegeneration
Johannes Burtscher, Mario Romani, Greta Bernardo, et al.
Progress in Neurobiology (2022) Vol. 215, pp. 102289-102289
Open Access | Times Cited: 23

Plasma ATN(I) classification and precision pharmacology in Alzheimer's disease
Bruno P. Imbimbo, Mark Watling, Camillo Imbimbo, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 10, pp. 4729-4734
Closed Access | Times Cited: 14

CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective
Elena Di Sabatino, Diana Ferraro, Lorenzo Gaetani, et al.
Journal of Neurology (2025) Vol. 272, Iss. 3
Open Access

Skin Biomarkers of Neurodegenerative Diseases
Lauren Reilly, Connor Bargar, Dominic Bunn, et al.
(2025), pp. 97-126
Closed Access

Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer’s Disease and Other Neurological Disorders
G. Bellomo, Antonio Indaco, Davide Chiasserini, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 32

Peripheral Inflammation Links with the Severity of Clinical Phenotype in Spinocerebellar Ataxia 2
Yaimeé Vázquez‐Mojena, Yanetsy Rodríguez‐Córdova, Yennis Domínguez-Barrios, et al.
Movement Disorders (2023) Vol. 38, Iss. 5, pp. 880-885
Closed Access | Times Cited: 12

Cerebrospinal fluid and blood serum biomarkers in neurodegenerative proteinopathies: A prospective, open, cross‐correlation study
Dorota Koníčková, Kateřina Menšíková, Kateřina Klíčová, et al.
Journal of Neurochemistry (2023) Vol. 167, Iss. 2, pp. 168-182
Open Access | Times Cited: 11

Page 1 - Next Page

Scroll to top